Consultation on Drug Quality Supervision in Medical Institutions

On October 28, the State Food and Drug Administration website began publicly soliciting opinions from various sectors of the society and relevant units and individuals on the Measures for the Administration of Drug Quality Supervision in Medical Institutions (draft for comment).

According to reports, in order to further strengthen the pharmaceutical quality management in medical institutions and ensure the quality and safety of the use of drugs, according to the "Drug Administration Law" and the "Regulations for the Implementation of the Drug Administration Law," the Department of Drug Safety Supervision of the State Food and Drug Administration drafted "Medical Institution Drugs. Quality Supervision and Management Measures (Draft for Comment).

The “Measures for the Administration of Pharmaceutical Quality Supervision in Medical Institutions” (draft for solicitation of opinions) is divided into 6 chapters and 41 articles, which are detailed in terms of channels, licenses, bills management, management of Chinese herbal medicines, storage requirements, classified storage, and cold storage.

The plan has now been publicly solicited on the website of the State Food and Drug Administration. Comments can be sent back by email, fax or post. The consultation period is from October 28, 2010 to November 15, 2010.